1. 2007:
    • SunWay Biotech Co., LTD. was established and its facility was qualified for GMP certification.
  2. 2008:
    • The research and technology of Monascus purpureus  NTU 568 (red yeast) and Lactobacillus paracasei  subsp. paracasei  NTU 101 (probiotics) were exclusively authorized by National Taiwan University.
    • Red yeast (Monascus purpureus) beverages were awarded the Certification of Symbol of National Quality (SNQ).
  3. 2009:
    • Developing red yeast products in capsule.
  4. 2010:
    • Probiotic products were awarded the Certification of Symbol of National Quality (SNQ).
    • Red yeast capsulate products were granted the Certification of Halal and the US federal trademark “HCW”.
  5. 2011:
    • The fermented manufacturing processes of red yeast-related products were granted patents and certificates from multiple nations.
  6. 2012:
    • The main facility was expanded and certified with ISO 22000 and HACCP.
    • Application and development of non-active Lactobacillus, collagen powder, and herbal tablets.
  7. 2013:
    • A red yeast product (ANKASCIN 568) was granted the Health Food Permit (No. A00231).
  8. 2014:
    • Development of Lactobacillus soft sweets.
  9. 2015:
    • The red yeast extract (ANKASCIN 568-R) was accepted by the US FDA as an NDI (New Dietary Ingredient)
    • Two clinical trials were completed in Taiwan, demonstrating ANKASCIN 568 Plus+ was effective in lowering blood glucose and blood lipids (total cholesterol and low-density lipoprotein cholesterol)
    • Red yeast and Lactobacillus ingredient supply and contract manufacturing of private label finished products.